Edmond de Rothschild Holding’s Traws Pharma TRAW Stock Holding History

Edmond de Rothschild Holding’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-267	Closed	-$2.98K	–	669
2024 Q2	$2.98K	Hold	267	–	–	﹤0.01%	656
2024 Q1	$6.73K	Hold	267	–	–	﹤0.01%	657
2023 Q4	$4.97K	Hold	267	–	–	﹤0.01%	671
2023 Q3	$4.74K	Hold	267	–	–	﹤0.01%	683
2023 Q2	$7.87K	Hold	267	–	–	﹤0.01%	692
2023 Q1	$4.87K	Hold	267	–	–	﹤0.01%	704
2022 Q4	$4.3K	Hold	267	–	–	﹤0.01%	761
2022 Q3	$6K	Buy	+267	New	+$8.07K	﹤0.01%	792
2022 Q2	–	Sell	-267	Closed	-$12K	–	883
2022 Q1	$12K	Buy	+267	New	+$12.4K	﹤0.01%	772
2021 Q3	–	Sell	-267	Closed	-$46K	–	870
2021 Q2	$46K	Hold	267	–	–	﹤0.01%	682
2021 Q1	$100K	Buy	+267	New	+$101K	﹤0.01%	567

Other funds holding TRAW

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

VWWMG

Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Edmond de Rothschild Holding's TRAW Position: Q3 2024 in Review

Edmond de Rothschild Holding sold out of Traws Pharma (TRAW) in Q3 2024, closing a stake of 267 shares — an estimated $2.98K sold.

Edmond de Rothschild Holding first reported a position in TRAW in Q1 2021 and held it in 11 quarters. The position peaked at $100K in Q1 2021. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2024.

Edmond de Rothschild Holding reported no remaining Traws Pharma position as of Q3 2024 after selling out during the quarter.
Edmond de Rothschild Holding sold 267 Traws Pharma shares in Q3 2024, an estimated $2.98K.
Edmond de Rothschild Holding first reported a position in Traws Pharma in Q1 2021 and held it in 11 quarters.
Edmond de Rothschild Holding's Traws Pharma position peaked at $100K in Q1 2021.
12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2024.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2024, filed 14 Nov 2024.